Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Market Cap	243.37B -23.5%
Revenue (ttm)	54.86B -36.5%
Net Income	-34.21B
EPS	-681.32
Shares Out	60.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,183,740
Open	3,885.00
Previous Close	3,925.00
Day's Range	3,625.00 - 4,305.00
52-Week Range	2,150.00 - 8,800.00
Beta	-0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps for offices, houses, apartments, buildings, factories, and parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps. The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon P...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 307
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082800

Financial Performance

In 2025, Vivozon Pharmaceutical's revenue was 59.34 billion, a decrease of -32.26% compared to the previous year's 87.60 billion. Losses were -32.42 billion, 224.8% more than in 2024.